Allergy Therapeutics appoints interim CFO

The British allergy company has hired a temporary chief financial officer until a permanent replacement is found.

Photo: Liz Hafalia/AP/Ritzau Scanpix

Allergy Therapeutics has hired a new, interim chief financial officer after Nick Wykeman, who spent six years serving the company, announced in May his departure on Nov. 30.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs